A detailed history of Washington Trust Advisors, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 36,625 shares of GMED stock, worth $3.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
36,625
Previous 38,805 5.62%
Holding current value
$3.1 Million
Previous $2.66 Million 1.39%
% of portfolio
0.23%
Previous 0.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$67.08 - $73.92 $146,234 - $161,145
-2,180 Reduced 5.62%
36,625 $2.62 Million
Q2 2024

Jul 25, 2024

SELL
$49.79 - $68.85 $2.38 Million - $3.29 Million
-47,830 Reduced 55.21%
38,805 $2.66 Million
Q1 2024

May 07, 2024

SELL
$51.15 - $56.52 $983,972 - $1.09 Million
-19,237 Reduced 18.17%
86,635 $4.65 Million
Q4 2023

Jan 18, 2024

SELL
$43.79 - $55.14 $2.83 Million - $3.57 Million
-64,680 Reduced 37.92%
105,872 $5.64 Million
Q3 2023

Oct 18, 2023

SELL
$49.1 - $62.37 $148,134 - $188,170
-3,017 Reduced 1.74%
170,552 $8.47 Million
Q2 2023

Jul 27, 2023

SELL
$52.61 - $59.54 $130,946 - $148,195
-2,489 Reduced 1.41%
173,569 $10.3 Million
Q1 2023

May 04, 2023

SELL
$51.83 - $79.63 $32,290 - $49,609
-623 Reduced 0.35%
176,058 $9.97 Million
Q4 2022

Feb 08, 2023

SELL
$58.4 - $75.53 $363,540 - $470,174
-6,225 Reduced 3.4%
176,681 $13.1 Million
Q3 2022

Oct 14, 2022

SELL
$55.32 - $67.54 $60,354 - $73,686
-1,091 Reduced 0.59%
182,906 $10.9 Million
Q2 2022

Jul 25, 2022

BUY
$53.08 - $81.37 $164,070 - $251,514
3,091 Added 1.71%
183,997 $10.3 Million
Q1 2022

May 05, 2022

BUY
$63.68 - $75.54 $75,524 - $89,590
1,186 Added 0.66%
180,906 $13.3 Million
Q4 2021

Feb 11, 2022

BUY
$62.62 - $79.92 $11.3 Million - $14.4 Million
179,720 New
179,720 $13 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.53B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.